Product NDC: | 49609-101 |
Proprietary Name: | Fludeoxyglucose F 18 |
Non Proprietary Name: | Fludeoxyglucose F-18 |
Active Ingredient(s): | 300 mCi/mL & nbsp; Fludeoxyglucose F-18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49609-101 |
Labeler Name: | IBA Molecular North America, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20111208 |
Package NDC: | 49609-101-01 |
Package Description: | 30 mL in 1 VIAL, MULTI-DOSE (49609-101-01) |
NDC Code | 49609-101-01 |
Proprietary Name | Fludeoxyglucose F 18 |
Package Description | 30 mL in 1 VIAL, MULTI-DOSE (49609-101-01) |
Product NDC | 49609-101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludeoxyglucose F-18 |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111208 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | IBA Molecular North America, Inc. |
Substance Name | FLUDEOXYGLUCOSE F-18 |
Strength Number | 300 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |